The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life (QoL) assessment in patients (pts) with K-RAS wild-type (WT) chemotherapy refractory metastatic colorectal cancer (mCRC) treated with cetuximab (CET) plus brivanib alaninate (BRIV) or placebo: Results of the NCIC Clinical Trials Group and AGITG CO.20 trial.
Jolie Ringash
No relevant relationships to disclose
Heather-Jane Au
No relevant relationships to disclose
Lillian L. Siu
Research Funding - Bristol-Myers Squibb
Jeremy D. Shapiro
Consultant or Advisory Role - Merck
Derek J. Jonker
No relevant relationships to disclose
John Raymond Zalcberg
No relevant relationships to disclose
Malcolm J. Moore
No relevant relationships to disclose
Andrew H. Strickland
Research Funding - Amgen
Rami Kotb
No relevant relationships to disclose
Mark Jeffery
No relevant relationships to disclose
Thierry Alcindor
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Siobhan Ng
No relevant relationships to disclose
Muhammad Salim
No relevant relationships to disclose
Sabe S. Sabesan
No relevant relationships to disclose
Jacob C. Easaw
No relevant relationships to disclose
Jennifer Anne Shannon
Consultant or Advisory Role - Merck
Fabyolla El-Tahche
No relevant relationships to disclose
Ian B. Walters
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Dongsheng Tu
No relevant relationships to disclose
Christopher J. O'Callaghan
No relevant relationships to disclose